Product Information
MYCOPHENOLATE 200 MG/ML SUSP is a generic product labeled by Aurobindo Pharma Limited, priced at $0.9816 per ML under NDC 59651064626. Its NADAC has been published 78 times since Apr 9, 2025.
FDA first approved this application on Sep 26, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/mL
Manufacturer
Aurobindo Pharma LimitedNDC
59651064626
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
MYCOPHENOLATE MOFETILApproval Type
Generic (ANDA)
FDA Application
ANDA218227FDA Approved
9/26/2024
TE Code
AB
On Market Since
9/26/2024
Pharmacological Classes
Price Statistics
The NADAC for MYCOPHENOLATE 200 MG/ML SUSP has been published 78 times since Apr 9, 2025, and over the history we have for it it has declined 41.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9816 per ML |
|---|---|
| All-time high | $1.7286 (Jul 16, 2025) |
| All-time low | $0.9324 (Jun 17, 2026) |
| 52-week high | $1.2816 |
| 52-week low | $0.9324 |
| Median price | $1.1622 |
| Average price | $1.2553 |
| Largest weekly change | -15.4% (Sep 17, 2025) |
| Weeks tracked | 78 |
| Tracking since | Apr 9, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the mycophenolate mofetil market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
mycophenolate mofetil market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antimetabolite Immunosuppressant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MYCOPHENOLATE 200 MG/ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for MYCOPHENOLATE 200 MG/ML SUSP, manufactured by Aurobindo Pharma Limited, is $0.9816 per ML (NDC 59651064626), effective Sep 30, 2026.
How has the price of MYCOPHENOLATE 200 MG/ML SUSP changed over time?
Over the history we have for it, the NADAC for MYCOPHENOLATE 200 MG/ML SUSP has declined 41.7%. It has been tracked across 78 weekly CMS publications since Apr 9, 2025.
What are the highest and lowest recorded NADAC prices for MYCOPHENOLATE 200 MG/ML SUSP?
Since Apr 9, 2025, the NADAC for MYCOPHENOLATE 200 MG/ML SUSP has ranged from a low of $0.9324 (Jun 17, 2026) to a high of $1.7286 (Jul 16, 2025), with a median of $1.1622 per ML.
Are there cheaper alternatives to MYCOPHENOLATE 200 MG/ML SUSP?
No other NADAC-published product currently shares the active ingredient and strength of MYCOPHENOLATE 200 MG/ML SUSP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures MYCOPHENOLATE 200 MG/ML SUSP?
MYCOPHENOLATE 200 MG/ML SUSP (NDC 59651064626) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.